retatrutide phase 2 obesity trial The data just dropped โ and is rewriting what's possible in medicine. ๐งฌ TRIUMPH-1 just released 3 results, and the numbers are unlike anything we've seen from a medication Triple hormone receptor agonist retatrutide
Description
In contrast to liraglutides effects in estrogen receptor-positive breast cancer, a recent in vitro study observed that liraglutide stimulates the growth of triple-negative breast cancer cells (Shadboorestan et al., 2021)
Nakamura H, Tanaka T, Zheng C, Afione SA, Warner BM, Noguchi M, et al
The goal isn't the highest dose
Are There Any Risks in Taking ULTRABRN
If you're not testing it, it's not uncommon for the dosages to be totally wrong
